Contact Us

DESTINATION NEWS

Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma

Feb 26, 2025

HEFEI,China,Feb. 25,2025-- Kangpu Biopharmaceuticals,Ltd. ("Kangpu") today announced that the Company has received IND approval from the CDE (Center for Drug Evaluation) of China National M

2025 MPA Awards to Honor "Wicked" Director, Key U.S. Lawmakers, and IPR Center

Feb 26, 2025

MPA Recognizes Chu with Creator Award,Sens. Thune and Coons and Rep. Issa with Industry Champion Awards,and IPR Center with Creative Protector Award

Gaudio Lab Returns to SXSW with an Immersive "Audio-Driven Campsite" Experience

Feb 26, 2025

AUSTIN,Texas,Feb. 25,2025-- Gaudio Lab,a leading innovator in AI-powered audio and spatial sound technology,will return to SXSW 2025,unveiling an immersive "audio-driven campsite" experience

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

Feb 26, 2025

MELBOURNE,Australia,Feb. 26,2025--Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted

Zeekr Group to Report Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025

Feb 25, 2025

HANGZHOU,China,Feb. 21,2025-- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK),the world\'s leading premium new energy vehicle group,today a

Yingli Solar's Global Product Workshop Successfully Held in Pakistan

Feb 25, 2025

ISLAMABAD,Feb. 21,2025-- Recently Yingli Solar kicked off its second Global Product Workshop under the theme "Powering the Future" in Islamabad,Pakistan. The event brought together over two

1 ... 74 75 76 77 78 79 80 ... 338